In the primary analysis, ANP significantly reduced 30-day mortality (RR: 0.63 [0.41–0.97]; P=0.04; I2=0%) and AKI (RR: 0.43 [0.33–0.56]; P<0.001; I2=0%). The gene discussed is NPPA; the disease is acute kidney injury.